Close Menu

A column in today's New York Times from Richard Friedman at the Weill Cornell Medical College says that psychiatrists may be able to prescribe antidepressants based on patients' genetic variants. In the past, he notes, such drugs have been doled out with a "hit-or-miss approach" until they strike the right balance with the patient. But these new genetic indicators seem promising in their ability to stratify patients and guide the therapeutic choice.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.